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Univentricular  pathway  is required  in  any  congenital  heart  disease  unsuitable  for  biventricular  repair.
In the  next  manuscript  we  will  describe  the  three  stages  of  univentricular  palliation,  i.e.  neonatal  palli-
ation,  Glenn  and  Fontan  procedures,  specially  focusing  on surgical  timing  and  complications,  as  well  as
indications  and  contraindications.
©  2013  Sociedad  Espan˜ola  de  Cirugía Torácica-Cardiovascular.  Published  by Elsevier  España,  S.L. All
rights  reserved.
Gestión  de  la  vía  univentricular
r  e  s  u  m  e  nalabras clave:
aliación univentricular
orwood
lenn
ontan
La  vía  univentricular  es necesaria  en  cualquier  anomalía  congénita  en  la  que  no  sea posible  realizar  una
reparación  biventricular  con éxito.  En  el  siguiente  manuscrito  describiremos  los  3  estadios  de paliación
univentricular,  es  decir,  la  paliación  neonatal,  Glenn  y  Fontan  y  enfatizaremos  especialmente  sobre  el
momento  de  su realización  y las  complicaciones,  así  como  sobre  las  indicaciones  y  las  contraindicaciones.
©  2013  Sociedad  Espan˜ola  de  Cirugía  Torácica-Cardiovascular.  Publicado  por Elsevier  España,  S.L.ntroduction
Univentricular heart management is needed for all cardiac
nomalies where successful biventricular repair is not possible.
A summary of management of patients with a univentricular
eart will be provided. Surgical management will be described for
he ﬁrst and preparatory neonatal procedures, the bidirectional
avopulmonary anastomosis (BCPA), the total cavopulmonary con-
ection (TCPC) and ﬁnally also for revision of older type of Fontan
perations to extracardiac TCPC. A time frame is suggested for these
teps as they are currently in use in the Leiden University Medical
enter.
Indications and contra-indications for these operations will be
iscussed, as well as complications and when possible, prognosis.
orms of univentricular heart
Univentricular heart means that only one cardiac ventricle is
vailable to support the systemic circulation. Many cardiac condi-
ions fall into this category: hypoplastic ventricles (hypoplastic left
eart syndrome (HLHS), pulmonary atresia with intact ventricu-
ar septum or hypoplastic right heart syndrome as well as several
ther anomalies with hypoplasia of one ventricle (e.g. unbalanced
trioventricular septal defect, transposition of the great arteries
ith one hypoplastic ventricle, double inlet left ventricle, double
E-mail address: m.g.hazekamp@lumc.nl
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outlet right ventricle (DORV) with hypoplasia of the left ventricle,
etc.), absent valve structures (e.g. tricuspid, mitral and sometimes
aortic atresia), straddling atrioventricular valves (e.g. double out-
let right ventricle with straddling tricuspid valve), abnormal valves
(hypoplastic mitral or aortic valves, extreme forms of Ebstein’s dis-
ease, etc.), many hearts with heterotaxy syndromes and also hearts
that possess two well-developed ventricles but where biventricu-
lar repair is not obtainable (e.g. giant VSD, DORV with straddling
tricuspid valve).
Management goals and contra-indications
The main goal of management of a univentricular heart or its
equivalent is to have one ventricle (or sometimes two  ventricles)
that supports the systemic circulation while direct cavopulmonary
connection is used for the pulmonary circulation. Thus, there will
not be a cardiac chamber to assist the pulmonary circulation. There
is only one exception here, namely in tricuspid atresia where in
older types of Fontan operations (direct or indirect (valved or non-
valved conduit) connection of right atrium to the (rudimentary) RV)
small RV was used to provide some assistance for the pulmonary
circulation.
As a consequence pulmonary blood ﬂow must be as smooth as
possible; an elevated pulmonary pressure or better, an elevated
pulmonary vascular resistance, hypoplastic or distorted pulmonary
arteries as well as obstructed pulmonary venous drainage are abso-
lute contra-indications for any form of cavopulmonary connection.
This also means that anything that increases pulmonary vascu-
lar resistance should be avoided. Hypertrophy of the systemic
ular. Published by Elsevier España, S.L. All rights reserved.
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entricle, stenotic or insufﬁcient valves of the systemic ventricle
ill eventually elevate pulmonary vascular resistance and this will
egatively inﬂuence the functioning of the cavopulmonary con-
ection. Anomalies of the cardiac rhythm will also decrease the
fﬁciency of the cavopulmonary connection.
All this has to be taken into account when entering the path-
ay towards total cavopulmonary connection. This means that
n the neonatal phase pulmonary overﬂow must be corrected as
his will lead to an increase in pulmonary vascular resistance that,
owever small this increase might be, will eventually result in an
mpaired functioning of the cavopulmonary connection. For the
ame reasons obstructive and regurgitant valves must be dealt with
t the earliest stage possible as they all will lead to ventricular
ypertrophy which in turn negatively affects pulmonary vascular
esistance. Pulmonary artery distortions and obstructions should
e avoided when constructing systemic to pulmonary shunts and
epair of anomalous pulmonary venous drainage should be done
s early as possible. Loss of sinus rhythm should be prevented,
specially when constructing the bidirectional cavopulmonary
nastomosis.
ime frame
Neonatal management is preferably performed in the ﬁrst
onth of life and for some conditions like HLHS even within the
rst 2 weeks after birth.
The second step is BCPA and is typically performed at an age
etween 4 and 8 months. In some instances this can be done ear-
ier (e.g. after Norwood/Sano procedure, when the Sano-shunt gets
bstructed) but not earlier than 3 months as pulmonary vascular
esistance has not decreased sufﬁciently as arborization of the pul-
onary arteries has not been concluded at that point. In case of
ouble vena cava superior it is usually wise to wait at least 8 months
s here the superior caval veins will be subsequently smaller and
ore vulnerable to obstruction.
The ﬁnal step is TCPC where the vena cava inferior is connected
o the (right) pulmonary artery by means of a Gore-Tex vascular
ube that is sufﬁciently wide for adult life. As this means a diameter
f 18–20 mm of the Gore-Tex tube, patient weight will have to be
t least 15 kg. This is normally at an age between 3 and 5 years.
When there is vena azygos continuation of the vena cava inferior
o a vena cava superior, cavopulmonary connection will be almost
omplete when the superior vena cava (or two, if there is also a
ersistent left vena cava superior) is connected to the pulmonary
rteries (Kawashima procedure). Only the hepatic and coronary
eins will not drain to the pulmonary arteries. This implies that
 Kawashima operation will be usually scheduled somewhere at
n age of 8–18 months.
Connection of the caval veins to the pulmonary arteries is done
n two steps: ﬁrst end-to-side anastomosis of the superior vena
ava to the (usually right) pulmonary artery (BCPA) and later TCPC
onnecting the vena cava inferior to the (usually right) pulmonary
rtery. Most high volume centers now avoid TCPC in one step as
he postoperative course is usually much less complicated when
avopulmonary connection is performed in two steps. Advantages
f connecting the vena cava superior to the pulmonary artery prior
o TCPC are several. There is sufﬁcient preload remaining for the
ystemic ventricle and unloading of the ventricle is more gradual.
urthermore, the BCPA may  be used as a ﬁnal palliation when TCPC
s not possible. Finally, the BCPA can be used as an intermediary
tep in a one-and-half ventricle repair.eonatal management
Neonatal management is aimed to create a pulmonary ﬂow
hat is balanced: if pulmonary ﬂow (e.g. pulmonary atresia) is. 2014;21(2):147–150
insufﬁcient a modiﬁed Blalock–Taussig shunt is made and if pul-
monary ﬂow is too high pulmonary artery banding is done. Both
procedures are done through a median sternotomy. This has sev-
eral advantages; a Blalock shunt can be placed more centrally both
on the brachiocephalic artery and on the pulmonary artery and is
easier to close at the next operation. A median sternotomy offers an
opportunity to inspect the rest of the cardiac anatomy and as all fur-
ther operations will be through the same approach there is evident
cosmetic beneﬁt. Finally, a median sternotomy offers full access for
cardiopulmonary bypass and is much safer than a lateral thoraco-
tomy. Typically, a 3.5–4.0 mm thin-walled Gore-Tex tube is used as
a modiﬁed Blalock-shunt as this preserves vascularity to the arm
and is easier to undo later. During surgery 1 mg/kg heparin is given
intravenously and the patient is placed on low dose of oral Aspirin
later on. For pulmonary artery banding a Teﬂon-band is used that
is ﬁxed into position by either a small hemoclip or a thin suture.
It is of importance to ﬁx the banding proximally to the pulmonary
artery wall in order to avoid distal migration and obstruction of the
PA-branches.
Another goal of neonatal management is to procure unob-
structed ﬂow to the aorta. In hypoplastic left heart syndrome or
equivalents (e.g. unbalanced AVSD with LV hypoplasia) this is done
by means of a Norwood procedure (with a modiﬁed Blalock-shunt
or a RV to PA (Sano)-shunt) that uses the pulmonary valve as the
main outlet valve. Some forms of univentricular heart (e.g. double
inlet left ventricle with coarctation) can be treated neonatally by
aortic arch repair and PA-banding; if the entrance to the aorta will
obstruct at a later stage this can be corrected at the time of the BCPA
with a Damus–Kaye–Stansel procedure.
Anomalous pulmonary venous drainage should be corrected as
soon as possible, especially when pulmonary venous drainage is
obstructed as this will result in elevation of pulmonary vascular
resistance that will have a negative inﬂuence on the functioning of
later cavopulmonary connections.
If possible, insufﬁcient atrioventricular valves should be
addressed and repaired in the neonatal phase although this can
be postponed and done at the time of BCPA.
It is important to evaluate the atrial septal communication and
to open this further either by interventional procedure (Rashkin
balloon atrioseptostomy) or by surgical atrioseptectomy.
Hybrid procedures are of recent interest: bilateral pulmonary
artery banding and maintaining the patency of the arterial duct
with prostaglandin infusion or with a stent can be beneﬁcial in
selected subgroups (e.g. hybrid Norwood).1–3
Management in infancy
The interstage interval between neonatal surgery and BCPA is
well-known to have a risk of mortality. For this reason infants
should be monitored very closely by a dedicated pediatric cardiol-
ogist. Many centers now have home monitoring programs directed
towards this speciﬁc group and some HLHS programs keep their
patients in hospital until they have received the BCPA.
Neonates and small infants are especially vulnerable after the
Norwood procedure because of the risk of coronary steal (by the
modiﬁed Blalock-shunt) that can rapidly result in cardiac ischemia
and death. After the Norwood/Sano variant RV-function may be
decreased because of the scar in the RV anterior wall or a rapid
obstruction of the Sano-shunt. Some univentricular hearts carry
a high risk of mortality after pulmonary artery banding and aor-
tic arch repair when there is a combined obstruction towards the
pulmonary and the systemic circulation.
In this phase between neonatal palliation and BCPA all infants
should thus be monitored very closely and the threshold for admit-
tance into the hospital should be very low.4
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anagement around bidirectional cavopulmonary anastomosis
Ideally BCPA should be performed between 4 and 8 months.
hen double vena cava superior is present BCPA must be bilateral
BCPA with only one vena cava superior will result in formation of
eno-venous collaterals between the vena cava superior that is still
onnected to the heart and the vena cava inferior and results in less
fﬁciency of the BCPA). If BCPA is bilateral it is wise to wait until
he child has reached a weight of approximately 8–10 kg. Superior
aval vein diameters are smaller when there are two superior caval
eins and technically, the operation is more difﬁcult.
As the sinus node resides in the zone between vena cava superior
nd right atrium there is always a risk to damage the sinus node
hen performing a BCPA. Therefore it is advised to always leave
 (very) short segment of superior caval vein attached to the right
trium and to take only very shallow suture bites when closing the
trial opening.
When performing a BCPA the vena azygos (or vena hemi-azygos
hen left-sided) has to be closed and divided in all instances.
eaving a vena (hemi-) azygos open will result in ﬂow from the
uperior vena cava system to the inferior caval vein system and
onsequently, a decreased performance of the BCPA.
At BCPA the vena cava superior is anastomosed end-to-side to
he pulmonary artery. Normally, this can be done without any patch
ut in some instances an autologous pericardial patch (untreated)
ay  be used to relieve any tension on the anastomosis or to aug-
ent the BCPA. Ideally, the ﬂow of the vena cava superior should
e directed more towards the right lung than to the left lung.
his is because the distribution of blood ﬂow to the right lung
s higher than towards the left lung. At the time of the TCPC the
ow from the vena cava inferior should preferably be directed
owards the left pulmonary artery. This will result in the best pos-
ible ﬂow proﬁles without any collision of superior and inferior
ows.
Sometimes it may  be reasonable to leave another source of addi-
ional ﬂow to the pulmonary artery. This can only be done when
ow is limited as too much ﬂow will result in backward ﬂow into
he vena cava superior and competition with BCPA function. A tight
anding of the pulmonary artery or a tight pulmonary stenosis may
e left untouched as these sources of (additional) forward ﬂow will
elp in postoperative recovery after BCPA with some increase in
xygen saturations.
When it is decided to disconnect the pulmonary artery from the
eart it is important to close the pulmonary valve as failure to do
o can result in later thrombus formation at that location (with a
isk of embolization into the aorta).
When oxygen saturations after BCPA are insufﬁcient it is advis-
ble to add a (small) modiﬁed Blalock-shunt and thus provide some
xtra pulmonary ﬂow. On the other hand and especially in young
nfants we know that it may  take some days for complete BCPA
unction and adequate oxygen saturations and for that reason we
ometimes can wait and in the meantime assist decrease of pul-
onary vascular resistance with nitrous oxide ventilation.
At the time of TCPC all sources of additional pulmonary ﬂow
hould be closed as they will negatively inﬂuence TCPC functioning.
fter TCPC there is no longer a need for additional oxygenation
nyway.
At the time of BCPA all remaining cardiac defect should be dealt
ith effectively to prepare the patient as good as possible for later
CPC. Remaining aortic arch obstructions should be repaired (nor-
ally with stent placement), when the ﬂow to the aorta is limited
ecause of a subaortic restriction (restrictive VSD, small LV outﬂow
ract, small aortic valve annulus or a valvular aortic stenosis) it must
e treated. Combining pulmonary and aortic valves and outlets can
e done by the Damus–Kaye–Stansel procedure where a double-
arreled cardiac outlet is formed. Any obstruction or regurgitation. 2014;21(2):147–150 149
of atrioventricular valves should be corrected as they will nega-
tively affect the functioning of the cavopulmonary connection. A
restrictive atrial septal communication must be opened whenever
necessary.
In the ﬁrst week after the BCPA the patient should be nursed in
a half-sitting position as this will decrease congestion of the upper
body half.
Management around total cavopulmonary connection
TCPC is performed using a extracardiac conduit in almost all
cases; only when a straight pathway from inferior vena cava to
pulmonary artery cannot be constructed, a lateral tunnel type TCPC
is done. As the extracardiac conduit needs to be sufﬁciently wide for
adult life, an 18 or 20 mm Gore-Tex vascular prosthesis is minimally
required. This implicates that the child needs to have a body weight
that is at least 15 kg.5 In our situation this will typically be around
3–4 years of age. In all cases we  use a fenestration of 4 mm diameter.
The fenestration will either close spontaneously later or is closed
1–3 years after TCPC in the cath lab.
TCPC is carried out on moderately hypothermic (28–30 ◦C) car-
diopulmonary bypass with bicaval cannulation and on beating
heart. Only when intracardiac repairs are needed, the aorta is cross-
clamped and the heart is arrested with cardioplegia. It is important
that the vena cava inferior is sufﬁciently developed and that the
cannula is placed at some distance from the atrium. First, the vena
cava inferior is detached from the atrium and the atrial opening
is temporarily clamped. The anastomosis between the Gore-Tex
tube and the vena cava inferior is made using a continuous 6-
0 Prolene suture. After this, a 4 mm fenestration is punched into
the Gore-Tex tube and then the atrial opening (where the vena
cava inferior was connected) is sewn to the Gore-Tex tube over
this fenestration. The tube is clamped to prevent air entering into
the heart. The right pulmonary artery is dissected at the underside
and freed from the left atrium. Then the right pulmonary artery
is clamped and longitudinally opened on its lower aspect. If clam-
ping is difﬁcult the CPB ﬂow is lowered and using a small-tipped
sucker is used to keep the pulmonary artery dry. The anastomo-
sis between right PA and the Goretex tube is usually beveled so
that there is some slight inclination towards the left pulmonary
artery. When 6-0 Prolene sutures are used it is not necessary
to use surgical glues. The Goretex tube is carefully de-aired and
all clamps are released. All remaining sources of additional pul-
monary ﬂow (e.g. an obstructed pulmonary valve or important
systemic to pulmonary collaterals) are closed as they may  inter-
fere with efﬁcient functioning of the TCPC. As in BCPA, we feel it is
important to repair all remaining valvular defects whenever pos-
sible. Then, the patient is rewarmed and with TEE the results are
controlled.
Postoperative management is usually smooth when a two-step
approach is used (ﬁrst BCPA and later TCPC) and when patient
selection has been properly done. It is not uncommon that in the
ﬁrst postoperative day ﬁlling pressures need to be maintained at
higher levels than normal. When inotropic support is needed this
will typically be a combination of milrinone and noradrenalin. It is
important to have pulmonary vascular resistance as low as possible
and for that reason early spontaneous ventilation and early ectu-
bation is encouraged. After TCPC pleural drain production can be
prolonged for days and in some cases even for weeks. Fluid restric-
tion, diuretics and patience will usually be sufﬁcient and drain
production will ﬁnally always stop.The fenestration between the external IVC to PA conduit and
the pulmonary venous atrium can result in some arterial desatura-
tion, arterial saturations will return to 100% after the fenestration
is closed.6–9
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nticoagulation
There is no general consensus on all aspects of anticoagulation
n the management of univentricular heart. We  will discuss here
ur anticoagulation policy brieﬂy. In the presence of a (Gore-Tex)
entral or (modiﬁed Blalock) aortopulmonary shunt, Aspirin is pre-
cribed to prevent shunt thrombosis. In BCPA no anticoagulation
s needed as there is tissue-to-tissue anastomosis, only in excep-
ional cases Aspirin may  be given. In the presence of a stent (e.g. in
he left pulmonary artery after the Norwood procedure) a combi-
ation of Aspirin and Clopidogrel is prescribed. All TCPC’s will have
ral anticoagulation with Cumadins and this should be continued
t least until the fenestration is closed; we feel however that either
umadin or Aspirin therapy should be prolonged lifelong in the
resence of a TCPC.10,11
In the direct postoperative phase subcutaneous administration
f low molecular weight heparin is usually given for thrombosis
revention.
ong-term follow-up
Rhythm disturbances are very frequent in patients with a Fontan
irculation. Rhythm disturbances are typically supraventricular
nd may  lead to an important decrease in the hemodynamic efﬁ-
iency of the Fontan circulation. Therefore it is important to address
his problem aggressively and if needed with transcatheter elec-
rophysiological ablation and wherever necessary with pacemaker
herapy.
Older types of Fontan circulation (atriopulmonary connections)
requently suffer from late dilatation of the right atrium. This will
esult in supraventricular tachycardias and stasis of blood ﬂow.
ogether with a diminished performance of the systemic ventricle
his may  ﬁnally end in multi-organ failure. Liver cirrhosis and kid-
ey failure are well-known to occur in adult patients with a Fontan
irculation.12–14
ontan conversion
Conversion of atriopulmonary Fontan circulations to extracar-
iac cavopulmonary connection can reverse dilatation of the right
trium, tachycardias and improve the hemodynamic efﬁciency of
hese patients. This should however be done before the patient
as become inoperable because of systemic ventricle failure, renal
nsufﬁciency and hepatic cirrhosis. Patient selection for Fontan to
CPC conversion should therefore be early and selective. Fontan
onversion is usually combined with (surgical) ablation therapy
mini Maze with radiofrequency ablation) and placement of per-
anent pacemaker leads and devices.
1. 2014;21(2):147–150
Limitations
Although in the majority of pediatric cardiac surgical units these
steps and time frames are followed, there are differences in man-
agement that are not fully described here. Some centers prefer a
hemi-Fontan procedure over a bidirectional cavopulmonary anas-
tomosis, as well as some use the lateral tunnel technique instead of
the extracardiac conduit technique to create a TCPC. Fenestrations
are not uniformally used and anticoagulation management is also
different around the globe.
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